Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease

Jennifer I. Lim, Christina Flaxel, Laurie LaBree

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Introduction: To review the long-term outcome of photodynamic therapy (PDT) with verteporfin for inflammatory chorioretinal disease with subfoveal choroidal neovascularisation (CNV) over a 1-year period. Materials and Methods: Retrospective review of eyes with subfoveal CNV for associated choroiditis that were treated with PDT using verteporfin over a 1-year period. Main outcome measure: visual acuity. Results: Five eyes in 4 patients, with diagnoses including serpiginous choroiditis (2), ocular histoplasmosis syndrome (OHS, 1), and punctate inner choroidopathy (PIC, 2) underwent standard treatment procedure for PDT with verteporfin. Visual acuity, fluorescein angiography and treatment parameters were reviewed. Follow-up ranged from 12 months to 36 months (median, 36 months). Pre-PDT visual acuities ranged from 20/60 to 20/400 (median, 20/200). Post-PDT visual acuities ranged from 20/30 to 20/400 at 1 year (median, 20/300). Visual acuity was stabilised (within 1 line) or improved (greater than 1 line) in 3 eyes at 1 year and 4 of the 5 eyes at last follow-up. Conclusion: PDT for subfoveal CNV may stabilise, but rarely improves, visual acuity in eyes with choroidal neovascularisation secondary to inflammatory chorioretinal disease.

Original languageEnglish (US)
Pages (from-to)198-202
Number of pages5
JournalAnnals of the Academy of Medicine Singapore
Volume35
Issue number3
StatePublished - Mar 2006
Externally publishedYes

Fingerprint

Choroidal Neovascularization
Photochemotherapy
Visual Acuity
Choroiditis
Histoplasmosis
Fluorescein Angiography
Outcome Assessment (Health Care)
Therapeutics
verteporfin

Keywords

  • Choroidal neovascularisation
  • Choroiditis
  • Photodynamic therapy
  • Verteporfin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease. / Lim, Jennifer I.; Flaxel, Christina; LaBree, Laurie.

In: Annals of the Academy of Medicine Singapore, Vol. 35, No. 3, 03.2006, p. 198-202.

Research output: Contribution to journalArticle

@article{3176a8114a5b448482bae180193d44f9,
title = "Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease",
abstract = "Introduction: To review the long-term outcome of photodynamic therapy (PDT) with verteporfin for inflammatory chorioretinal disease with subfoveal choroidal neovascularisation (CNV) over a 1-year period. Materials and Methods: Retrospective review of eyes with subfoveal CNV for associated choroiditis that were treated with PDT using verteporfin over a 1-year period. Main outcome measure: visual acuity. Results: Five eyes in 4 patients, with diagnoses including serpiginous choroiditis (2), ocular histoplasmosis syndrome (OHS, 1), and punctate inner choroidopathy (PIC, 2) underwent standard treatment procedure for PDT with verteporfin. Visual acuity, fluorescein angiography and treatment parameters were reviewed. Follow-up ranged from 12 months to 36 months (median, 36 months). Pre-PDT visual acuities ranged from 20/60 to 20/400 (median, 20/200). Post-PDT visual acuities ranged from 20/30 to 20/400 at 1 year (median, 20/300). Visual acuity was stabilised (within 1 line) or improved (greater than 1 line) in 3 eyes at 1 year and 4 of the 5 eyes at last follow-up. Conclusion: PDT for subfoveal CNV may stabilise, but rarely improves, visual acuity in eyes with choroidal neovascularisation secondary to inflammatory chorioretinal disease.",
keywords = "Choroidal neovascularisation, Choroiditis, Photodynamic therapy, Verteporfin",
author = "Lim, {Jennifer I.} and Christina Flaxel and Laurie LaBree",
year = "2006",
month = "3",
language = "English (US)",
volume = "35",
pages = "198--202",
journal = "Annals of the Academy of Medicine, Singapore",
issn = "0304-4602",
publisher = "Academy of Medicine Singapore",
number = "3",

}

TY - JOUR

T1 - Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease

AU - Lim, Jennifer I.

AU - Flaxel, Christina

AU - LaBree, Laurie

PY - 2006/3

Y1 - 2006/3

N2 - Introduction: To review the long-term outcome of photodynamic therapy (PDT) with verteporfin for inflammatory chorioretinal disease with subfoveal choroidal neovascularisation (CNV) over a 1-year period. Materials and Methods: Retrospective review of eyes with subfoveal CNV for associated choroiditis that were treated with PDT using verteporfin over a 1-year period. Main outcome measure: visual acuity. Results: Five eyes in 4 patients, with diagnoses including serpiginous choroiditis (2), ocular histoplasmosis syndrome (OHS, 1), and punctate inner choroidopathy (PIC, 2) underwent standard treatment procedure for PDT with verteporfin. Visual acuity, fluorescein angiography and treatment parameters were reviewed. Follow-up ranged from 12 months to 36 months (median, 36 months). Pre-PDT visual acuities ranged from 20/60 to 20/400 (median, 20/200). Post-PDT visual acuities ranged from 20/30 to 20/400 at 1 year (median, 20/300). Visual acuity was stabilised (within 1 line) or improved (greater than 1 line) in 3 eyes at 1 year and 4 of the 5 eyes at last follow-up. Conclusion: PDT for subfoveal CNV may stabilise, but rarely improves, visual acuity in eyes with choroidal neovascularisation secondary to inflammatory chorioretinal disease.

AB - Introduction: To review the long-term outcome of photodynamic therapy (PDT) with verteporfin for inflammatory chorioretinal disease with subfoveal choroidal neovascularisation (CNV) over a 1-year period. Materials and Methods: Retrospective review of eyes with subfoveal CNV for associated choroiditis that were treated with PDT using verteporfin over a 1-year period. Main outcome measure: visual acuity. Results: Five eyes in 4 patients, with diagnoses including serpiginous choroiditis (2), ocular histoplasmosis syndrome (OHS, 1), and punctate inner choroidopathy (PIC, 2) underwent standard treatment procedure for PDT with verteporfin. Visual acuity, fluorescein angiography and treatment parameters were reviewed. Follow-up ranged from 12 months to 36 months (median, 36 months). Pre-PDT visual acuities ranged from 20/60 to 20/400 (median, 20/200). Post-PDT visual acuities ranged from 20/30 to 20/400 at 1 year (median, 20/300). Visual acuity was stabilised (within 1 line) or improved (greater than 1 line) in 3 eyes at 1 year and 4 of the 5 eyes at last follow-up. Conclusion: PDT for subfoveal CNV may stabilise, but rarely improves, visual acuity in eyes with choroidal neovascularisation secondary to inflammatory chorioretinal disease.

KW - Choroidal neovascularisation

KW - Choroiditis

KW - Photodynamic therapy

KW - Verteporfin

UR - http://www.scopus.com/inward/record.url?scp=33745203261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745203261&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 198

EP - 202

JO - Annals of the Academy of Medicine, Singapore

JF - Annals of the Academy of Medicine, Singapore

SN - 0304-4602

IS - 3

ER -